119 related articles for article (PubMed ID: 29517108)
1. Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Oncol Rep; 2018 May; 39(5):2422-2426. PubMed ID: 29517108
[TBL] [Abstract][Full Text] [Related]
2. Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Guglielmi G; Frenzilli G; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 May; 17(5):6914-6918. PubMed ID: 29532885
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Frenzilli G; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 May; 17(5):7415-7420. PubMed ID: 29568907
[TBL] [Abstract][Full Text] [Related]
4. CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 Aug; 18(2):1798-1803. PubMed ID: 29901202
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Ghiri E; Crescioli C; Romagnani P; Vitti P; Serio M; Ferrannini E
Cytokine; 2010 Jun; 50(3):260-7. PubMed ID: 20299237
[TBL] [Abstract][Full Text] [Related]
6. Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation.
Gallardo-Vera F; Diaz D; Tapia-Rodriguez M; Fortoul van der Goes T; Masso F; Rendon-Huerta E; Montaño LF
J Immunotoxicol; 2016; 13(1):27-37. PubMed ID: 25565016
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.
Antonelli A; Ferrari SM; Frascerra S; Corrado A; Pupilli C; Bernini G; Benvenga S; Ferrannini E; Fallahi P
Exp Cell Res; 2011 Jul; 317(11):1527-33. PubMed ID: 21565188
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
9. Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Di Domenicantonio A; Galleri D; Santarpia L; Basolo F; Ferrannini E; Miccoli P
Cytokine; 2012 Aug; 59(2):218-22. PubMed ID: 22633083
[TBL] [Abstract][Full Text] [Related]
10. Vanadium pentoxide induces activation and death of endothelial cells.
Montiel-Dávalos A; Gonzalez-Villava A; Rodriguez-Lara V; Montaño LF; Fortoul TI; López-Marure R
J Appl Toxicol; 2012 Jan; 32(1):26-33. PubMed ID: 21721017
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
Antonelli A; Ferrari SM; Mancusi C; Mazzi V; Pupilli C; Centanni M; Ferri C; Ferrannini E; Fallahi P
Immunobiology; 2013 May; 218(5):690-5. PubMed ID: 22944249
[TBL] [Abstract][Full Text] [Related]
12. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.
Crescioli C; Cosmi L; Borgogni E; Santarlasci V; Gelmini S; Sottili M; Sarchielli E; Mazzinghi B; Francalanci M; Pezzatini A; Perigli G; Vannelli GB; Annunziato F; Serio M
J Endocrinol; 2007 Oct; 195(1):145-55. PubMed ID: 17911406
[TBL] [Abstract][Full Text] [Related]
13. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
14. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells].
Song Y; Lin Q; Zheng J; Zhu X; Yang S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
Antonelli A; Ferrari SM; Frascerra S; Pupilli C; Mancusi C; Metelli MR; Orlando C; Ferrannini E; Fallahi P
J Clin Endocrinol Metab; 2010 Dec; 95(12):E413-20. PubMed ID: 20810571
[TBL] [Abstract][Full Text] [Related]
16. Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.
Fluhr H; Seitz T; Zygmunt M
Breast Cancer Res Treat; 2013 Jan; 137(1):109-18. PubMed ID: 23160925
[TBL] [Abstract][Full Text] [Related]
17. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.
García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M
J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578
[TBL] [Abstract][Full Text] [Related]
18. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
19. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Piaggi S; Gelmini S; Lupi C; Minuto M; Berti P; Benvenga S; Basolo F; Orlando C; Miccoli P
Endocr Relat Cancer; 2009 Dec; 16(4):1299-311. PubMed ID: 19755523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
